As Opioid Use Declines, Gabapentinoid Co-Prescribing Rises

As Opioid Use Declines, Gabapentinoid Co-Prescribing Rises

(MedPage Today) -- The number of U.S. patients prescribed long-term opioid therapy declined from 2015 to 2023, but co-prescribing of opioids with gabapentinoids increased, prescription data showed. In 2023, 4.2 million people had an active long...

Long-term opioid prescribing has fallen, but millions still receive extended opioid therapy

Long-term opioid prescribing has fallen in the United States over the last decade, but millions of patients still received opioids for 90 days or longer in 2023, according to a new research letter in JAMA led by University of Michigan researchers. The team analyzed U.S. trends in long-term opioid therapy, a pattern of opioid dispensing often used for chronic pain but associated with risks, including overdose and addiction.

Study Finds Long-Term Opioid Prescriptions Decline, Yet Millions Continue

In the evolving landscape of pain management in the United States, a recent comprehensive analysis led by researchers from the University of Michigan unveils a nuanced transformation in long-term opioid prescribing patterns over the past decade. Published in the prestigious journal JAMA, this research letter meticulously examines trends from 2015 to 2023, revealing both progress and persistent challenges in the chronic use of opioids for pain th…